A precision medicine approach for HCN1 Developmental and Epileptic Encephalopathy
Lauren E. Bleakley, Chaseley E. McKenzie, Da You Zhao…·Christopher A. Reid
This study evaluates the therapeutic potential of Org 34167, an HCN channel inhibitor, for HCN1-DEE using multiple assays, showing efficacy in reducing cation leak and seizures but with side effects.